Platelet Mass Signatures and Thrombin-Activatable Fibrinolysis Inhibitor as Discriminators of Primary Thrombocytosis: Development of a Screening Algorithm in an Eastern Sudanese Cohort
Cureus · 31.03.2026
DOI: 10.7759/cureus.106174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 31.03.2026. Verfasst von Bashir A Bashir. Beteiligte Einrichtung: Department of Hematology, Faculty of Medical Laboratory Sciences, Port Sudan Ahlia University, Port Sudan, SDN. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Faculty of Medical Laboratory Sciences, Port Sudan Ahlia University, Port Sudan, SDN.
Zitieren
APA
Bashir, B. A. (2026). Platelet Mass Signatures and Thrombin-Activatable Fibrinolysis Inhibitor as Discriminators of Primary Thrombocytosis: Development of a Screening Algorithm in an Eastern Sudanese Cohort. Cureus. https://doi.org/10.7759/cureus.106174
Vancouver
Bashir BA. Platelet Mass Signatures and Thrombin-Activatable Fibrinolysis Inhibitor as Discriminators of Primary Thrombocytosis: Development of a Screening Algorithm in an Eastern Sudanese Cohort. Cureus. 2026. doi:10.7759/cureus.106174
BibTeX
@article{Bashir2026,
author = {Bashir, Bashir A},
title = {Platelet Mass Signatures and Thrombin-Activatable Fibrinolysis Inhibitor as Discriminators of Primary Thrombocytosis: Development of a Screening Algorithm in an Eastern Sudanese Cohort},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.106174}
}
EUVIMED